Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
RYTM
RYTM
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
RYTM News
Stock Investment Opportunities in May
May 07 2026
Fool
Rhythm Pharmaceuticals Reports Strong Earnings, IMCIVREE Demand Surges
May 06 2026
Newsfilter
Rhythm Pharmaceuticals Surges 8% After Strong Quarterly Earnings Report
May 06 2026
Fool
Rhythm Pharmaceuticals Q1 2026 Earnings Call Highlights
May 05 2026
seekingalpha
RHYTHM PHARMACEUTICALS STOCK JUMPS 7.5% IN PREMARKET TRADING FOLLOWING Q1 REVENUE INCREASE
May 05 2026
moomoo
Rhythm Pharmaceuticals Q1 2026 Earnings Report Analysis
May 05 2026
seekingalpha
Rhythm Pharmaceuticals to Announce Q1 Earnings on May 5
May 04 2026
seekingalpha
Rhythm Pharmaceuticals Expands IMCIVREE Approval in Europe
May 04 2026
NASDAQ.COM
RHYTHM PHARMACEUTICALS UNVEILS NEW DATA ON ACQUIRED HYPOTHALAMIC OBESITY AT PEDIATRIC ENDOCRINE SOCIETY CONFERENCE
May 04 2026
moomoo
Rhythm Pharmaceuticals Secures EU Approval for Novel Therapy
May 01 2026
Yahoo Finance
Rhythm Pharmaceuticals Appoints New Board Member
Apr 03 2026
NASDAQ.COM
Rhythm Pharmaceuticals Gains FDA Approval for Expanded Market
Mar 31 2026
Fool
Rhythm Pharmaceuticals Receives EMA Support for Imcivree Label Expansion
Mar 26 2026
seekingalpha
Rhythm Pharmaceuticals Receives Positive EMA Opinion for IMCIVREE Expansion
Mar 26 2026
Newsfilter
PANTHERx Selected as Exclusive U.S. Pharmacy Partner for IMCIVREE Distribution
Mar 20 2026
PRnewswire
PANTHERx Selected as Exclusive U.S. Pharmacy Partner for IMCIVREE Distribution
Mar 20 2026
Newsfilter
Show More News
